Molly(R) Modular Platform Autoinjector
Products
Information
Molly is a single-dose autoinjector technology developed to help pharma and biotech companies reduce initial investments and expedite development timelines. Built on a proven modular platform, Molly reduces risks during the development process while increasing flexibility in device design and production. Available in 1.0 mL and 2.25 mL variations, products using Molly autoinjectors have been approved and launched in 14 molecular entities covering at least 25 clinical indications in a variety of standard and customized designs around the world. For more information, go to: https://molly.shl-medical.com/
Distribution Areas
North America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesSouth America (e.g. Brazil, Colombia)
Supplied From
Switzerland
All categories
Finished Dosage FormsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)InjectablesPackaging Materials and EquipmentMedical Devices and Medical PackagingContract ManufacturingDrug Delivery Devices & SystemsInjectable systems and componentsCost-effective injectorAuto-injectorProductsServices
Main Categories
Finished Dosage FormsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)Packaging Materials and EquipmentDrug Delivery Devices & Systems
